𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunohistochemical detection of transforming growth factor-β1 in fibrotic liver diseases

✍ Scribed by Peter Nagy; Zsuzsa Schaff; Károly Lapis


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
1004 KB
Volume
14
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Transforming growth factor-$, was localized by means of immunohistochemical reaction in liver biopsy specimens taken from patients having different chronic liver diseases with extending fibrosis. Two polyclonal antibodies that were produced in rabbits were directed against the amino terminal of transforming growth factor-p,.

Staining by anti-CC(1-30) was primarily extracellular and located in the portal and periportal fibrotic areas of a l l seven cases with chronic active hepatitis. No staining was noted in the four chronic persistent cases studied. A strong reaction was seen with the antibody in nine of the ten cirrhotic samples, whereas it was negative in one inactive cirrhosis case and in all five cases with normal liver histological findings. No positive staining could be detected by the anti-LC( 1-30) in any of the liver tissues.

Detection of transforming growth factor-$, in active liver diseases at the site of fibrosis suggests that transforming growth factor-$, might have a role in the process and progression of fibrosis during the development of the disease. (HEPATOLOGY 1991;14:269-273.)

Increased deposition of extracellular matrix is a characteristic change in several chronic liver diseases, especially in cirrhosis (1-4). The exact factors that are responsible for this accumulation are unknown. Considering the similarities in histopathological features for cirrhosis and chronic hepatitis, as well as the polyetiological origin of both, we considered common factors that could be responsible for fibrosis in the liver during several pathological conditions. One candidate for such a factor is transforming growth factor-p, (TGF-@,I.

TGF-P, is a multifunctional growth factor. It is presumed to play a role in the regulation of many physiological and pathological processes (5). The first recognized in uiuo effect was the stimulation of wound healing (6). The deposition of extracellular matrix is the most important event during the process of scar formation in the late phase of wound healing. For this reason, it was proposed that TGF-P, may have an influence on the metabolism of extracellular matrix


📜 SIMILAR VOLUMES


Expression of hepatocyte growth factor,
✍ M Masuhara; M Yasunaga; K Tanigawa; F Tamura; S Yamashita; I Sakaida; K Okita 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

After a partial hepatectomy, TGF-a mRNA has been shown of chronic liver disease; CH, chronic hepatitis; LC, liver cirrhosis; LI, labeling index; RTto increase in hepatocytes at the time of DNA synthesis con-PCR, reverse-transcriptase polymerase chain reaction; cDNA, complementary DNA.

Levels of transforming growth factor β a
✍ Bettina Grasl-Kraupp; Walter Rossmanith; Branislav Ruttkay-Nedecky; Leonhard Mül 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Transforming growth factor β 1 (TGF-β 1 ) has been implicated as inhibitor of cell proliferation and a potent inducer of apoptosis in vitro and in vivo after the administration of high doses. To assess the role of endogenous TGF-β 1 , we quantitated the cytokine and its receptors in rat liver during

Differential expression of hepatocyte gr
✍ Masaaki Masuhara; Sikandar L. Katyal; Toshikazu Nakamura; Hisashi Shinozuka 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 1021 KB

Hepatocyte growth factor, a potent hepatocyte mitogen in vitro, appears to trigger hepatocyte regeneration after partial hepatectomy and after acute liver cell netcrosis. Transforming growth factor-a and transforming growth factor+, may also be involved in the control of liver regeneration. In this

Transforming growth factor-β1 regulates
✍ Massimo Pinzani; Alessandra Gentilini; Alessandra Caligiuri; Raffaella De Franco 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 901 KB

Activated liver fat-storing cells (FSC) are known to play a key role in the development of liver fibrosis. An important element in FSC activation process is the increased expression of receptors for platelet-derived growth factor (PDGF), a potent mitogen for FSC. The aim of the present study was to